Practical issues in the application of oxygenases

Trends in Biotechnology

Volumn 21, Issue 4, 2003, Pages 170-177

  Van Beilen, Jan B ^a   Duetz, Wouter A ^b   Schmid, Andreas ^a   Witholt, Bernard ^a  

^a ETH ZURICH   (Switzerland)

^b Enzyscreen BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR DYNAMICS; OXIDATION; TOXIC MATERIALS;

OXYGENASES;

ENZYMES;

OXYGEN; OXYGENASE;

ENZYME;

BIOTRANSFORMATION; CATALYSIS; MOLECULE; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS; PSEUDOMONAS MENDOCINA; PSEUDOMONAS PUTIDA; REVIEW; STEREOCHEMISTRY;

NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS MENDOCINA; PSEUDOMONAS PUTIDA;

EID: 0242500462     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(03)00032-5     Document Type: Review

References (77)

1. Straathof A.J.J., et al. The production of fine chemicals by biotransformations. Curr. Opin. Biotechnol. 13:2002;548-556.
2. Biotechnology for clean industrial products and processes. 1998;OECD, Paris, France.
3. Davies H.G., et al. Biotransformations in preparative organic chemistry. 1989;Academic Press, London, UK.
4. Azerad R. Microbial models for drug metabolism. Adv. Biochem. Eng. Biotechnol. 63:1999;169-218.
5. Duetz W.A., et al. Using proteins in their natural environment: potential and limitations of microbial whole-cell hydroxylations in applied biocatalysis. Curr. Opin. Biotechnol. 12:2001;419-425.
6. Witholt B., et al. Bioconversions of aliphatic compounds by Pseudomonas oleovorans in multiphase biorectors: background and economic potential. Trends Biotechnol. 8:1990;46-52.
7. Holland H.L. Organic synthesis with oxidative enzymes. 1991;VCH Publishers, Inc, New York, NY, USA.
8. Holland H.L., Weber H.K. Enzymatic hydroxylation reactions. Curr. Opin. Biotechnol. 11:2000;547-553.
9. Li Z., et al. Oxidative biotransformations using oxygenases. Curr. Opin. Chem. Biol. 6:2002;136-144.
10. Duetz W.A., et al. Methods for intense aeration, growth, storage, and replication of bacterial strains in microtiter plates. Appl. Environ. Microbiol. 66:2000;2641-2646.
11. Doig S.D., et al. The use of microscale processing technologies for quantification of biocatalytic Baeyer-Villiger oxidation kinetics. Biotechnol. Bioeng. 80:2002;42-49.
12. Kiener A. Enzymatic oxidation of methyl groups on aromatic heterocycles: a versatile method for the preparation of heteroaromatic carboxylic acids. Angew. Chem. Int. Ed. Engl. 31:1992;774-775.
13. Wong J.W., et al. Biocatalytic oxidation of 2-methylquinoxaline to 2-quinoxalinecarboxylic acid. Org. Process Res. Dev. 6:2002;477-481.
14. Duetz W.A., et al. Biotransformation of D-limonene to (+) trans-carveol by toluene-grown Rhodococcus opacus PWD4 cells. Appl. Environ. Microbiol. 67:2001;2829-2832.
15. Resnick S.M., et al. Diverse reactions catalyzed by naphthalene dioxygenase from Pseudomonas sp. strain NCIB 9816. J. Ind. Microbiol. Biotechnol. 17:1996;438-457.
16. Colonna S., et al. First asymmetric epoxidation catalysed by cyclohexanone monooxygenase. Tetrahedron Lett. 43:2002;1797-1799.
17. van der Werf M.J., et al. Rhodococcus erythropolis DCL14 contains a novel degradation pathway for limonene. Appl. Environ. Microbiol. 65:1999;2092-2102.
18. Pikus J.D., et al. Changes in the regiospecificity of aromatic hydroxylation produced by active site engineering in the diiron enzyme toluene 4-monooxygenase. Biochemistry. 36:1997;9283-9289.
19. Li Z., et al. Preparation of optically active N-benzyl-3-hydroxypyrrolidine by enzymatic hydroxylation. Tetrahedron Asymmetry. 10:1999;1323-1333.
20. Guengerich F.P., et al. Heterologous expression of human drug-metabolizing enzymes. Drug Metab. Dispos. 25:1997;1234-1241.
21. Cirino P.C., Arnold F.H. Protein engineering of oxygenases for biocatalysis. Curr. Opin. Chem. Biol. 6:2002;130-135.
22. Panke S., et al. An alkane-responsive expression system for the production of fine chemicals. Appl. Environ. Microbiol. 65:1999;2324-2332.
23. Hüsken L.E., et al. Optimisation of microbial 3-methylcatechol production as affected by culture conditions. Biocat. Biotrans. 20:2002;57-61.
24. Loida P.J., Sligar S.G. Molecular recognition in cytochrome P-450: Mechanism for the control of uncoupling reactions. Biochemistry. 32:1993;11530-11538.
25. Lee K. Benzene-induced uncoupling of naphthalene dioxygenase activity and enzyme inactivation by production of hydrogen peroxide. J. Bacteriol. 181:1999;2719-2725.
26. Suske W.A., et al. Purification and characterization of 2-hydroxybiphenyl-3-monooxygenase, a novel NADH-dependent, FAD-containing aromatic hydroxylase from Pseudomonas azelaica HBP1. J. Biol. Chem. 272:1997;24257-24265.
27. Miles C.S., et al. Protein engineering of cytochromes P-450. Biochim. Biophys. Acta. 1543:2000;383-407.
28. Jones J.P., et al. Oxidation of polychlorinated benzenes by genetically engineered CYP101 (cytochrome P450cam). Eur. J. Biochem. 268:2001;1460-1467.
29. Meyer A., et al. Changing the substrate reactivity of 2-hydroxybiphenyl 3-monooxygenase from Pseudomonas azelaica HBP1 by directed evolution. J. Biol. Chem. 277:2002;5575-5582.
30. Held M., et al. An integrated process for the production of toxic catechols from toxic phenols based on a designer biocatalyst. Biotechnol. Bioeng. 62:1999;641-648.
31. Boddupalli S.S., et al. Fatty acid monooxygenation by P450-BM-3: Product identification and proposed mechanisms for the sequential hydroxylation reactions. Arch. Biochem. Biophys. 292:1992;20-28.
32. Munro A.W., et al. P450 BM3: The very model of a modern flavocytochrome. Trends Biochem. Sci. 27:2002;250-257.
33. Ortiz De Montellano P.R., et al. Nitric oxide synthase structure and electron transfer. Drug Metab. Dispos. 26:1998;1185-1189.
34. Lee K., Gibson D.T. Toluene and ethylbenzene oxidation by purified naphthalene dioxygenase from Pseudomonas sp. strain NCIB 9816-4. Appl. Environ. Microbiol. 62:1996;3101-3106.
35. Holmberg-Betsholtz I., et al. Sterol 27-hydroxylase in bile acid biosynthesis: Mechanism of oxidation of 5-beta-cholestane-3-alpha,7-alpha,12-alpha-27-tetrol into 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoic acid. J. Biol. Chem. 268:1993;11079-11085.
36. Bühler B., et al. Characterization and application of xylene monooxygenase for multistep biocatalysis. Appl. Environ. Microbiol. 68:2002;560-568.
37. Katopodis A.G., et al. Mechanistic studies on non-heme iron monooxygenase catalysis: epoxidation, aldehyde formation, and demethylation by the ω-hydroxylation system of Pseudomonas oleovorans. J. Am. Chem. Soc. 106:1984;7928-7935.
38. Sibbesen O., et al. Putidaredoxin reductase-putidaredoxin-cytochrome P450cam triple fusion protein: construction of a self-sufficient Escherichia coli catalytic system. J. Biol. Chem. 271:1996;22462-22469.
39. Shet M.S., et al. The omega-hydroxylation of lauric acid: oxidation of 12-hydroxylauric acid to dodecanedioic acid by a purified recombinant fusion protein containing p450 4A1 and NADPH-P450 reductase. Arch. Biochem. Biophys. 330:1996;199-208.
40. Hazzard J.T., et al. Electron transfer between the FMN and heme domains of cytochrome P450BM-3 - Effects of substrate and CO. J. Biol. Chem. 272:1997;7922-7926.
41. Honeychurch M.J., et al. The thermodynamics and kinetics of electron transfer in the cytochrome P450cam enzyme system. FEBS Lett. 451:1999;351-353.
42. Schneider S., et al. Controlled regioselectivity of fatty acid oxidation by whole cells producing cytochrome P450BM-3 monooxygenase under varied dissolved oxygen concentrations. Biotechnol. Bioeng. 64:1999;333-341.
43. Staijen I.E., et al. Expression, stability and performance of the three-component alkane monooxygenase of Pseudomonas oleovorans in Escherichia coli. Eur. J. Biochem. 267:2000;1957-1965.
44. Murdock D., et al. Construction of metabolic operons catalyzing the de novo biosynthesis of indigo in Escherichia coli. Biotechnology. 11:1993;381-386.
45. Richardson T.H., et al. A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. Arch. Biochem. Biophys. 323:1995;87-96.
46. Hugo N., et al. A novel (2Fe-2S) ferredoxin from Pseudomonas putida mt2 promotes the reductive reactivation of catechol 2,3-dioxygenase. J. Biol. Chem. 273:1998;9622-9629.
47. Chen Q., et al. Physiological changes and alk gene instability in Pseudomonas oleovorans during induction and expression of alk genes. J. Bacteriol. 178:1996;5508-5512.
48. Nieboer M., et al. The alkane oxidation system of Pseudomonas oleovorans: induction of the alk-genes in Escherichia coli W3110 affects membrane biogenesis and results in overexpression of alkane hydroxylase in a distinct cytoplasmic membrane subfraction. Mol. Microbiol. 8:1993;1039-1051.
49. Panke S., et al. Engineering of a stable whole-cell biocatalyst capable of (S)-styrene oxide formation for continuous two-liquid phase applications. Appl. Environ. Microbiol. 65:1999;5619-5623.
50. Hüsken L.E., et al. High-rate 3-methylcatechol production in Pseudomonas putida strains by means of a novel expression system. Appl. Microbiol. Biotechnol. 55:2001;571-577.
51. Laane C., et al. Rules for optimization of biocatalysis in organic solvents. Biotechnol. Bioeng. 30:1987;81-87.
52. Schmid A., et al. Developments toward large-scale bacterial bioprocesses in the presence of bulk amounts of organic solvents. Extremophiles. 2:1998;249-256.
53. Ramos J.L., et al. Mechanisms of solvent tolerance in Gram-negative bacteria. Annu. Rev. Microbiol. 56:2002;743-768.
54. Doig S.D., et al. Large scale production of cyclohexanone monooxygenase from Escherichia coli TOP10 pQR239. Enzyme Microb. Technol. 28:2001;265-274.
55. Panke S., et al. Pilot-scale production of (S)-styrene oxide from styrene by recombinant Escherichia coli synthesizing styrene monooxygenase. Biotechnol. Bioeng. 80:2002;33-41.
56. Shet M.S., et al. The function of recombinant cytochrome P450s in intact Escherichia coli cells: The 17-alpha-hydroxylation of progesterone and pregnenolone by P450c17. Arch. Biochem. Biophys. 339:1997;218-225.
57. Panke S., et al. Production of enantiopure styrene oxide by recombinant Escherichia coli synthesizing a two-component styrene monooxygenase. Biotechnol. Bioeng. 69:2000;91-100.
58. Schmid A., et al. Development of equipment and procedures for the safe operation of aerobic bacterial bioprocesses in the presence of bulk amounts of flammable organic solvents. Bioprocess Eng. 20:1999;91-100.
59. Buckland B.C., et al. The enzymatic transformation of water-insoluble reactants in nonaqueous solvents. Conversion of cholesterol to cholest-4-ene-3-one by a Nocardia sp. Biotechnol. Bioeng. 67:2000;714-719.
60. Hesselink P.G.M., et al. Optimization of steroid side chain cleavage by Mycobacterium sp. in the presence of cyclodextrins. Enzyme Microb. Technol. 11:1989;398-404.
61. Shibasaki T., et al. Construction of a novel hydroxyproline-producing recombinant Escherichia coli by introducing a proline 4-hydroxylase gene. J. Biosci. Bioeng. 90:2000;522-525.
62. Berry A., et al. Application of metabolic engineering to improve both the production and use of biotech indigo. J. Ind. Microbiol. Biotechnol. 28:2002;127-133.
63. Haudenschild C., et al. Functional expression of regiospecific cytochrome P450 limonene hydroxylase from mint (Mentha spp.) in Escherichia coli and Saccharomyces cerevisia. Arch. Biochem. Biophys. 379:2000;127-136.
64. Martin V.J.J., et al. The in vivo synthesis of plant sesquiterpenes by Escherichia coli. Biotechnol. Bioeng. 75:2001;497-503.
65. Kim S., Keasling J.D. Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production. Biotechnol. Bioeng. 72:2001;408-415.
66. Lotan T., Hirshberg J. Cloning and expression in Escherichia coli of the gene encoding beta-C-4-oxygenase, that converts beta-carotene to the ketocarotenoid canthaxanthin in Haematococcus pluvialis. FEBS Lett. 364:1995;125-128.
67. Mathys R.G., et al. Integrated two-liquid phase bioconversion and product-recovery processes for the oxidation of alkanes: process design and economic evaluation. Biotechnol. Bioeng. 64:1999;459-477.
68. Liese A., et al. Industrial biotransformations. 2000;Wiley-VCH, Wienheim, Germany.
69. Serizawa N., Matsuoka T. A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Biochim. Biophys. Acta. 1084:1991;35-40.
70. Dingler C., et al. Preparation of (R)-2-(4-Hydroxyphenoxy) propionic acid by biotransformation. Pestic. Sci. 46:1996;33-35.
71. Gbewonyo K., et al. Development of a large-scale continuous substrate feed process for the biotransformation of simvastatin by Nocardia sp. Biotechnol. Bioeng. 37:1991;1101-1107.
72. Hanson R.L., et al. Hydroxylation of mutilin by Streptomyces griseus and Cunninghamella echinulata. Org. Process Res. Dev. 6:2002;482-487.
73. Wackett L.P., Hershberger C.D. Biocatalysis and biodegradation. 2001;ASM Press, Washington DC, USA.
74. Tinschert A., et al. Novel regioselective hydroxylations of pyridine carboxylic acids at position C2 and pyrazine carboxylic acids at position C3. Appl. Microbiol. Biotechnol. 53:2000;185-195.
75. Kahng H.Y., et al. Characterization and role of tbuX in utilization of toluene by Ralstonia pickettii PKO1. J. Bacteriol. 182:2000;1232-1242.
76. Doig S.D., et al. Reactor operation and scale-up of whole cell Baeyer-Villiger catalyzed lactone synthesis. Biotechnol. Prog. 18:2002;1039-1046.
77. Panke S., Wubbolts M.G. Enzyme technology and bioprocess engineering. Curr. Opin. Biotechnol. 13:2002;111-116.